Mingxin Xuteng announced that the company's stock rose 33.14% for three consecutive trading days from July 27 to 29, 2026, which is an abnormal fluctuation. The company expects a net loss of 35 to 52 million yuan for the half year of 2026. The holding subsidiary Liaoning Fuxin has stopped production, and the estimated impairment is about 10 million yuan. The company's robotics business is only in the R&D stage, with no mass production, no orders or revenue. Furthermore, the company has no important undisclosed information that should be disclosed, reminding investors of risks such as transactions, performance, and conceptual hype.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.